Cite
MLA Citation
Owen A. O'Connor et al.. “The addition of granulocyte-colony stimulating factor shifts the dose limiting toxicity and markedly increases the maximum tolerated dose and activity of the kinesin spindle protein inhibitor SB-743921 in patients with relapsed or refractory lymphoma: results of an international, multicenter phase I/II study.” Leukemia & lymphoma, vol. 56, no. 9, n.d., pp. 2585–2591. http://access.bl.uk/ark:/81055/vdc_100089569417.0x000029